US EditionHawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
- The Hawaii court ordered the manufacturers and distributors of Plavix to pay the state $916 million for failing to disclose medication efficacy and safety.
- Initially, the lawsuit resulted in a $834 million judgement in 2014, with companies appealing to the Hawaii Supreme Court.
- The second trial confirmed a $916 million judgement split equally between Bristol-Myers Squibb and Sanofi-Aventis.
22 Articles
22 Articles
National Post
Financial PostHawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
HONOLULU (AP) -- A Hawaii court has ordered the manufacturers and distributors of the blood thinner Plavix to pay the state a combined $916 million after finding the companies failed to disclose the efficacy and safety of the medication, the state attorney general said Tuesday.
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
HONOLULU (AP) — A Hawaii court has ordered the manufacturers and distributors of the blood thinner Plavix to pay the state a combined $916 million after finding the companies failed to disclose the efficacy and safety of the medication, the state att
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
By AUDREY McAVOY Associated Press HONOLULU (AP) — Hawaii’s attorney general says a court has ordered the manufacturers and distributors of the blood thinner Plavix to pay the state a combined $916 million after finding the companies failed to disclose the efficacy and safety of the medication. The state court judgement was issued against Bristol Myers Squibb Company and three U.S.-based subsidiaries of French pharmaceutical company Sanofi. The c…
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit
By AUDREY McAVOY Associated Press HONOLULU (AP) — Hawaii’s attorney general says a court has ordered the manufacturers and distributors of the blood thinner Plavix to pay the state a combined $916 million after finding the companies failed to disclose the efficacy and safety of the medication. The state court judgement was issued against Bristol
Coverage Details
Bias Distribution
- 44% of the sources lean Left
To view factuality data please Upgrade to Premium
